Loading the map…

Residential nursing care facilities · Sheffield, South Yorkshire

Morar Uxbridge

Morar Uxbridge Ltd

Net liabilitiesActiveLatest figures: 2025Abridged accountsCompany only2 years on the register

Private limited company registered in Sheffield, classed under “Residential nursing care facilities” and 1 other activity.

Headline figures

FY to May 2025 · Company only

Turnover

For subscribers

Profit after tax

—

Not filed: small-company exemption

Net assets

For subscribers

Cash

For subscribers

Employees

For subscribers

Retained reserves

For subscribers

What the numbers say

1 finding from the figures, in plain English

Written by rules from the figures on this page. Not a forecast or a credit opinion.

History

Pro
£2025
Profit after tax—
Turnover
Net assets
Cash
Employees
Retained reserves

Every figure for the year

“—” means we did not find the figure in a source; it is never filled with an estimate.

Balance sheet and ratios

From the filed balance sheets · £

Balance sheet2025
Current assets
of which debtors
Net current assets
Net assets

4 balance-sheet lines, every year

A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.

Questions people ask

›What does Morar Uxbridge do?

Private limited company registered in Sheffield, classed under “Residential nursing care facilities” and 1 other activity.

›How much turnover does Morar Uxbridge make?

Answered in the full report

›Is Morar Uxbridge profitable?

Morar Uxbridge's profit isn't public: small companies may file without a profit and loss account.

›How many people work at Morar Uxbridge?

Answered in the full report

›Where is Morar Uxbridge based?

Its registered office is 524 Admin Office, Grimesthorpe Road, Sheffield, South Yorkshire, S4 8LE, in Sheffield, South Yorkshire.

›When was Morar Uxbridge founded?

Morar Uxbridge Ltd was incorporated on 16 May 2024.

›Is Morar Uxbridge still trading?

The register lists Morar Uxbridge Ltd as active.